A methodology for determining which diseases warrant care in a high-level containment care unit

Research output: Contribution to journalArticle

Abstract

Although the concept of high-level containment care (HLCC or ‘biocontainment’), dates back to 1969, the 2014–2016 outbreak of Ebola virus disease (EVD) brought with it a renewed emphasis on the use of specialized HLCC units in the care of patients with EVD. Employment of these units in the United States and Western Europe resulted in a significant decrease in mortality compared to traditional management in field settings. Moreover, this employment appeared to significantly lessen the risk of nosocomial transmission of disease; no secondary cases occurred among healthcare workers in these units. While many now accept the wisdom of utilizing HLCC units and principles in the management of EVD (and, presumably, of other transmissible and highly hazardous viral hemorrhagic fevers, such as those caused by Marburg and Lassa viruses), no consensus exists regarding additional diseases that might warrant HLCC. We propose here a construct designed to make such determinations for existing and newly discovered diseases. The construct examines infectivity (as measured by the infectious dose needed to infect 50% of a given population (ID50)), communicability (as measured by the reproductive number (R0)), and hazard (as measured by morbidity and mortality). Diseases fulfilling all three criteria (i.e., those that are highly infectious, communicable, and highly hazardous) are considered candidates for HLCC management if they also meet a fourth criterion, namely that they lack effective and available licensed countermeasures.

Original languageEnglish (US)
Article number773
JournalViruses
Volume11
Issue number9
DOIs
StatePublished - Sep 1 2019

Fingerprint

Ebola Hemorrhagic Fever
Lassa virus
Marburgvirus
Viral Hemorrhagic Fevers
Mortality
Disease Outbreaks
Patient Care
Morbidity
Delivery of Health Care
Population

Keywords

  • Biocontainment
  • Communicability
  • Ebola virus disease
  • High-level containment care
  • Highly hazardous communicable disease
  • Infectivity

ASJC Scopus subject areas

  • Infectious Diseases
  • Virology

Cite this

A methodology for determining which diseases warrant care in a high-level containment care unit. / Cieslak, Theodore J; Herstein, Jocelyn J.; Kortepeter, Mark G; Hewlett, Angela L.

In: Viruses, Vol. 11, No. 9, 773, 01.09.2019.

Research output: Contribution to journalArticle

@article{433d0cea4b0646f99b56ba159c5c8607,
title = "A methodology for determining which diseases warrant care in a high-level containment care unit",
abstract = "Although the concept of high-level containment care (HLCC or ‘biocontainment’), dates back to 1969, the 2014–2016 outbreak of Ebola virus disease (EVD) brought with it a renewed emphasis on the use of specialized HLCC units in the care of patients with EVD. Employment of these units in the United States and Western Europe resulted in a significant decrease in mortality compared to traditional management in field settings. Moreover, this employment appeared to significantly lessen the risk of nosocomial transmission of disease; no secondary cases occurred among healthcare workers in these units. While many now accept the wisdom of utilizing HLCC units and principles in the management of EVD (and, presumably, of other transmissible and highly hazardous viral hemorrhagic fevers, such as those caused by Marburg and Lassa viruses), no consensus exists regarding additional diseases that might warrant HLCC. We propose here a construct designed to make such determinations for existing and newly discovered diseases. The construct examines infectivity (as measured by the infectious dose needed to infect 50{\%} of a given population (ID50)), communicability (as measured by the reproductive number (R0)), and hazard (as measured by morbidity and mortality). Diseases fulfilling all three criteria (i.e., those that are highly infectious, communicable, and highly hazardous) are considered candidates for HLCC management if they also meet a fourth criterion, namely that they lack effective and available licensed countermeasures.",
keywords = "Biocontainment, Communicability, Ebola virus disease, High-level containment care, Highly hazardous communicable disease, Infectivity",
author = "Cieslak, {Theodore J} and Herstein, {Jocelyn J.} and Kortepeter, {Mark G} and Hewlett, {Angela L}",
year = "2019",
month = "9",
day = "1",
doi = "10.3390/v11090773",
language = "English (US)",
volume = "11",
journal = "Viruses",
issn = "1999-4915",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "9",

}

TY - JOUR

T1 - A methodology for determining which diseases warrant care in a high-level containment care unit

AU - Cieslak, Theodore J

AU - Herstein, Jocelyn J.

AU - Kortepeter, Mark G

AU - Hewlett, Angela L

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Although the concept of high-level containment care (HLCC or ‘biocontainment’), dates back to 1969, the 2014–2016 outbreak of Ebola virus disease (EVD) brought with it a renewed emphasis on the use of specialized HLCC units in the care of patients with EVD. Employment of these units in the United States and Western Europe resulted in a significant decrease in mortality compared to traditional management in field settings. Moreover, this employment appeared to significantly lessen the risk of nosocomial transmission of disease; no secondary cases occurred among healthcare workers in these units. While many now accept the wisdom of utilizing HLCC units and principles in the management of EVD (and, presumably, of other transmissible and highly hazardous viral hemorrhagic fevers, such as those caused by Marburg and Lassa viruses), no consensus exists regarding additional diseases that might warrant HLCC. We propose here a construct designed to make such determinations for existing and newly discovered diseases. The construct examines infectivity (as measured by the infectious dose needed to infect 50% of a given population (ID50)), communicability (as measured by the reproductive number (R0)), and hazard (as measured by morbidity and mortality). Diseases fulfilling all three criteria (i.e., those that are highly infectious, communicable, and highly hazardous) are considered candidates for HLCC management if they also meet a fourth criterion, namely that they lack effective and available licensed countermeasures.

AB - Although the concept of high-level containment care (HLCC or ‘biocontainment’), dates back to 1969, the 2014–2016 outbreak of Ebola virus disease (EVD) brought with it a renewed emphasis on the use of specialized HLCC units in the care of patients with EVD. Employment of these units in the United States and Western Europe resulted in a significant decrease in mortality compared to traditional management in field settings. Moreover, this employment appeared to significantly lessen the risk of nosocomial transmission of disease; no secondary cases occurred among healthcare workers in these units. While many now accept the wisdom of utilizing HLCC units and principles in the management of EVD (and, presumably, of other transmissible and highly hazardous viral hemorrhagic fevers, such as those caused by Marburg and Lassa viruses), no consensus exists regarding additional diseases that might warrant HLCC. We propose here a construct designed to make such determinations for existing and newly discovered diseases. The construct examines infectivity (as measured by the infectious dose needed to infect 50% of a given population (ID50)), communicability (as measured by the reproductive number (R0)), and hazard (as measured by morbidity and mortality). Diseases fulfilling all three criteria (i.e., those that are highly infectious, communicable, and highly hazardous) are considered candidates for HLCC management if they also meet a fourth criterion, namely that they lack effective and available licensed countermeasures.

KW - Biocontainment

KW - Communicability

KW - Ebola virus disease

KW - High-level containment care

KW - Highly hazardous communicable disease

KW - Infectivity

UR - http://www.scopus.com/inward/record.url?scp=85071458700&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071458700&partnerID=8YFLogxK

U2 - 10.3390/v11090773

DO - 10.3390/v11090773

M3 - Article

VL - 11

JO - Viruses

JF - Viruses

SN - 1999-4915

IS - 9

M1 - 773

ER -